Barry Cheskin, president and CEO of
NanoGram Devices commented, "We chose to partner with EaglePicher because of their decades of experience developing and manufacturing high performance batteries.
By partnering with OTB we are integrating the expertise and proprietary technology of two companies working to speed the time-to-market of
NanoGram's SilFoil technology," said Dr Kieran Drain, president and CEO of
NanoGram Corporation.
Paul Kloppenborg, CEO of Global Cleantech Capital and an experienced solar investor who was one of the early active investors in Renewable Energy Corporation (REC) and Q-Cells, states, "We believe that by helping
NanoGram to commercialize their proprietary solar knowledge we accelerate our own solar investment program to deliver the high efficiencies of crystalline silicon with the cost savings of thin film.
NeoPhotonics Corporation, founded in 1996 as
Nanogram Corporation, develops and manufactures advanced planar optical devices by monolithically integrating active and passive optical materials using the company's proprietary nanomaterials-based process solutions.
Nanogram quantities of cells, tissue, blood, or body fluids can be mixed directly with eTag reagents in standard 96-well laboratory microplates.
Patients were randomized into one of two treatment groups: 800
nanogram PH80 up to four times daily during six consecutive days or placebo.
Participating CEOs hail from companies like Nucryst Pharmaceuticals,
Nanogram, NanoTerra, Lumera, Altair Nano, Starpharma, Integran, Kereos, AION Diagnostics, Advanced Nanotechnology, Sirtris Pharmaceuticals, NanoOpto, and NanoBioMagnetics.
NanoGram Corporation, Nanomaterials Laboratory, NanoSperse LLC, Nanosys, Inc.
The simple process enables researchers to perform uniform and unbiased amplification of as little as one
nanogram of cDNA, and takes only 15 additional minutes of hands-on time and 1.
NanoGram Corporation, a leading developer and licensor of core process technology enabling the manufacture of unique nanostructured materials for optical, electronic and energy applications, announced today that it has developed high transparency, high refractive index polymer nanocomposites.
In a pooled analysis of all participants, subjects whose vitamin D levels were classified as high at an average of 30
nanograms per milliliter experienced a 44% reduction in breast cancer mortality risk when compared to those whose levels were low at 17
nanograms per milliliter.
When they looked at deaths from all causes and cardiovascular disease specifically, those with blood levels of 21
nanograms per milliliter of 25-Hydroxyvitamin D - at the top of the range that the IOM considers "adequate" and at the low end of "normal" - cut their risk of death in half.
